NCT00300404 Effect of Specific Anti-Toxoplasmatic Add-on Medication in Toxoplasma Gondii Seropositive Individuals With Schizophrenia or Major Depression Status COMPLETED Phase PHASE3
NCT00296725 Dichotic Listening as a Predictor of Medication Response in Depression Status COMPLETED Phase PHASE1/PHASE2
NCT00296712 Are Two Antidepressants a Good Initial Treatment for Depression? Status COMPLETED Phase PHASE4
NCT00296686 Sequential Tranylcypromine (TC), TC + Dextroamphetamine and TC + Triiodothyronine for Refractory Depression Status TERMINATED Phase PHASE4
NCT00295347 Mineralocorticoid Receptor in the Treatment of Severe Depression Status COMPLETED Phase NA
NCT00291239 Effect of Partial Sleep Deprivation on Cognition and Cytokines in Individuals With Major Depression Status UNKNOWN Phase PHASE4
NCT00289484 A Study of Omega-3 as an Augmentor of Antidepressant Treatment for Major Depression Status UNKNOWN Phase PHASE2
NCT00285766 Safety, Tolerability and Efficacy of the Transdermal System in Elderly Subjects With Major Depression Status COMPLETED Phase PHASE3
NCT00265291 Antidepressant Treatment of Mexican-Americans: UCLA Pharmacogenetics and Pharmacogenomics Research Group Status COMPLETED Phase PHASE2
NCT00249886 Discontinuation Study Of Citalopram (Antidepressant) in Depressed Adolescents Status WITHDRAWN Phase PHASE3
NCT00222820 Depression: The Search for Treatment-Relevant Phenotypes-Pilot Study Status COMPLETED Phase PHASE4
NCT00220623 Efficacy of 18-Months of Antidepressive Medication Plus CBT or Dynamic or Supportive Psychotherapy for Recurrent Major Depression Status UNKNOWN Phase PHASE3